Citation: Ww. Hauck et al., CONSIDERATIONS IN THE ATTAINMENT OF STEADY-STATE - AGGREGATE VS. INDIVIDUAL ASSESSMENT, Pharmaceutical research, 15(11), 1998, pp. 1796-1798
Citation: A. Gelman et Fy. Bois, ANALYSIS OF NONRANDOMLY CENSORED ORDERED CATEGORICAL LONGITUDINAL DATA FROM ANALGESIC TRIALS - COMMENT, Journal of the American Statistical Association, 92(440), 1997, pp. 1248-1250
Authors:
TOZER TN
BOIS FY
HAUCK WW
CHEN ML
WILLIAMS RL
Citation: Tn. Tozer et al., ABSORPTION RATE VS EXPOSURE - WHICH IS MORE USEFUL FOR BIOEQUIVALENCETESTING, Pharmaceutical research, 13(3), 1996, pp. 453-456
Citation: Fy. Bois et al., MODELING HUMAN INTERINDIVIDUAL VARIABILITY IN METABOLISM AND RISK - THE EXAMPLE OF 4-AMINOBIPHENYL, Risk analysis, 15(2), 1995, pp. 205-213
Authors:
WATANABE KH
BOIS FY
DAISEY JM
AUSLANDER DM
SPEAR RC
Citation: Kh. Watanabe et al., BENZENE TOXICOKINETICS IN HUMANS - EXPOSURE OF BONE-MARROW TO METABOLITES, Occupational and environmental medicine, 51(6), 1994, pp. 414-420
Citation: Fy. Bois et B. Eskenazi, POSSIBLE RISK OF ENDOMETRIOSIS FOR SEVESO, ITALY, RESIDENTS - AN ASSESSMENT OF EXPOSURE TO DIOXIN, Environmental health perspectives, 102(5), 1994, pp. 476-477
Citation: Tj. Woodruff et al., EVALUATING HEALTH RISKS FROM OCCUPATIONAL EXPOSURE TO PESTICIDES AND THE REGULATORY RESPONSE, Environmental health perspectives, 102(12), 1994, pp. 1088-1096
Citation: Rc. Spear et Fy. Bois, PARAMETER VARIABILITY AND THE INTERPRETATION OF PHYSIOLOGICALLY-BASEDPHARMACOKINETIC MODELING RESULTS, Environmental health perspectives, 102, 1994, pp. 61-66
Citation: Bg. Reigner et al., PENTACHLOROPHENOL CARCINOGENICITY - EXTRAPOLATION OF RISK FROM MICE TO HUMANS, Human & experimental toxicology, 12(3), 1993, pp. 215-225
Citation: Tj. Woodruff et Fy. Bois, OPTIMIZATION ISSUES IN PHYSIOLOGICAL TOXICOKINETIC MODELING - A CASE-STUDY WITH BENZENE, Toxicology letters, 69(2), 1993, pp. 181-196